Riki Okita
Overview
Explore the profile of Riki Okita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
779
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsubara K, Yamamoto H, Okita R, Otani S, Watanabe M, Ueno T, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
2(4):603-607.
PMID: 39790604
Background: Lung cancer with interstitial pneumonia is known to be a refractory disease. We explored whether systemic inflammatory response markers are associated with outcomes in these patients. Methods: The participants...
2.
Okita R, Senoo T, Mimura-Kimura Y, Mimura Y, Murakami T, Ikeda E, et al.
Sci Rep
. 2024 Jul;
14(1):15947.
PMID: 38987362
The clinical impact of soluble molecules in pleural effusion (PE) is unclear in patients with malignant pleural mesothelioma (MPM). In this single-center, retrospective, observational study, we assessed soluble forms of...
3.
Li C, Huang Y, Yi X, Tang Y, Okita R, He J
Transl Cancer Res
. 2024 May;
13(4):1936-1953.
PMID: 38737690
Background: Natural killer (NK) cells play a significant role in antitumor immunity and are closely related to tumor prognosis and recurrence. NK cell-based tumor immunotherapy, including immune checkpoint inhibition and...
4.
Kawamoto N, Okita R, Okada M, Hayashi M, Inokawa H
AME Case Rep
. 2024 Jan;
8:8.
PMID: 38234337
Background: Chylothorax is an intractable postoperative complication of thoracic surgery. Preventing postoperative chylothorax following initial surgery is important. Most cases of chylothorax are caused by injury to the thoracic duct...
5.
Tanaka A, Okita R, Morishige T, Okada M, Inokawa H, Hirazawa K, et al.
Thorac Cancer
. 2023 Dec;
15(4):353-357.
PMID: 38131508
A 61-year-old woman, who had a history of total thyroidectomy for follicular variant of papillary thyroid carcinoma (PTC), visited our hospital for assessment of an enlarging nodule which appeared in...
6.
Okita R, Kawamoto N, Okada M, Inokawa H, Yamamoto N, Murakami T, et al.
Sci Rep
. 2023 Mar;
13(1):5263.
PMID: 37002247
We assessed the prognostic value of five complex inflammatory and nutritional parameters, namely neutrophil-to-lymphocyte ratio (NLR), prognostic nutritional index (PNI), C-reactive protein-to-NLR ratio (C/NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio...
7.
Okazaki M, Suzawa K, Shien K, Yamamoto H, Araki K, Watanabe M, et al.
Eur J Cardiothorac Surg
. 2023 Feb;
63(3).
PMID: 36752515
Objectives: Ipsilateral reoperation after pulmonary lobectomy is often challenging because of adhesions from the previous operation. We retrospectively examined the surgical outcome and prognosis of ipsilateral anatomical resection for lung...
8.
Okita R, Mimura-Kimura Y, Kawamoto N, Yamamoto N, Umeda M, Okada M, et al.
Cancer Immunol Immunother
. 2022 Sep;
72(4):865-879.
PMID: 36115921
Programmed cell death protein-1 (PD1), PD1 ligand 1 (PD-L1), and human leukocyte antigen (HLA) class I molecule play pivotal roles in T cell-induced anti-tumor immunity; however, the clinical impact of...
9.
Okita R, Okada M, Inokawa H, Murakami T, Ikeda E
Surg Oncol
. 2022 Jul;
43:101813.
PMID: 35816852
Introduction: A preoperative validation system for predicting the clinical outcome of extrapleural pneumonectomy (EPP) for malignant pleural mesothelioma (MPM) is required, as EPP for MPM is one of the most...
10.
Takatsu F, Suzawa K, Okazaki M, Shien K, Yamamoto H, Watanabe M, et al.
Ann Thorac Surg
. 2022 May;
117(1):181-188.
PMID: 35595090
Background: In survivors of head and neck cancer (HNC), second primary lung cancer (SPLC) often develop as a result of a common risk factor, that is, smoking. A multicenter experience...